Press Releases 2021
Liminal BioSciences Provides Update on Business Strategy and Focus on Small Molecule Therapeutics
LMNL focused on continued advancement of its small molecule therapeutics platform including development of fezagepras and evaluating strategic alternatives for its plasma-derived therapeutics entity.
Liminal BioSciences Receives FDA Approval for its US-based Plasma Collection Center
Prometic Plasma Resources (USA) Inc., has received U.S. Food and Drug Administration (“FDA”) approval for its plasma collection center located in Amherst, NY.